References/Publications for Lymphocyte proliferation assay of Ara h 2

Check all              

Select PubMed ID Description
8308186 J Allergy Clin Immunol. 1994 Jan;93(1 Pt 1):93-9.

The production of interferon-gamma in response to a major peanut allergy, Ara h
II correlates with serum levels of IgE anti-Ara h II.

Dorion BJ(1), Burks AW, Harbeck R, Williams LW, Trumble A, Helm RM, Leung DY.


15575928 Allergy. 2005 Jan;60(1):35-40.

Characterization of the T-cell epitopes of a major peanut allergen, Ara h 2.

Glaspole IN(1), de Leon MP, Rolland JM, O'Hehir RE.


16189800 Mol Nutr Food Res. 2005 Oct;49(10):963-71.

Allergenic characteristics of a modified peanut allergen.

King N(1), Helm R, Stanley JS, Vieths S, Lüttkopf D, Hatahet L, Sampson H, Pons
L, Burks W, Bannon GA.


21093025 J Allergy Clin Immunol. 2011 Mar;127(3):608-15.e1-5. doi:
1016/j.jaci.2010.09.027. Epub 2010 Nov 18.

Ara h 2 peptides containing dominant CD4+ T-cell epitopes: candidates for a
peanut allergy therapeutic.

Prickett SR(1), Voskamp AL, Dacumos-Hill A, Symons K, Rolland JM, O'Hehir RE.


29885257 Allergy. 2018 Oct;73(10):2080-2082. doi: 10.1111/all.13498. Epub 2018 Jul 2.

Major hazelnut and peanut allergens are potent in basophil activation and
cross-react at T-cell level.

Masthoff LJN(1), Pasmans SGMA(1), van Doorn H(1), den Hartog Jager CF(1),
Geneugelijk K(1), Knol EF(1)(2), Bruijnzeel-Koomen CAFM(1), Lidholm J(3), Knulst
AC(1), Hoffen E(1).


30414861 J Allergy Clin Immunol. 2018 Nov 8. pii: S0091-6749(18)31581-1. doi:
1016/j.jaci.2018.10.039. [Epub ahead of print]

Engineering of structural variants of the major peanut allergens Ara h 2 and Ara
h 6 for allergen-specific immunotherapy.

Bublin M(1), Kostadinova M(1), Radauer C(1), Varga EM(2), Hafner C(3),
Schmidthaler K(4), Saidova A(4), Maleki SJ(5), Szépfalusi Z(4), Eiwegger T(6),
Breiteneder H(1).